92 related articles for article (PubMed ID: 23708756)
1. The histone deacetylase inhibitor vorinostat prevents TNFα-induced necroptosis by regulating multiple signaling pathways.
Wang D; Zhao M; Chen G; Cheng X; Han X; Lin S; Zhang X; Yu X
Apoptosis; 2013 Nov; 18(11):1348-1362. PubMed ID: 23708756
[TBL] [Abstract][Full Text] [Related]
2. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.
Zhong HM; Ding QH; Chen WP; Luo RB
Int Immunopharmacol; 2013 Oct; 17(2):329-35. PubMed ID: 23856614
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes.
Wang JH; Shih KS; Wu YW; Wang AW; Yang CR
Osteoarthritis Cartilage; 2013 Dec; 21(12):1987-96. PubMed ID: 24107356
[TBL] [Abstract][Full Text] [Related]
4. Curbing autophagy and histone deacetylases to kill cancer cells.
Gammoh N; Marks PA; Jiang X
Autophagy; 2012 Oct; 8(10):1521-2. PubMed ID: 22894919
[TBL] [Abstract][Full Text] [Related]
5. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
6. TNFα-induced necroptosis and autophagy via supression of the p38-NF-κB survival pathway in L929 cells.
Ye YC; Yu L; Wang HJ; Tashiro S; Onodera S; Ikejima T
J Pharmacol Sci; 2011; 117(3):160-9. PubMed ID: 22027097
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for neurotropic action of vorinostat, a pan histone deacetylase inhibitor.
Shukla S; Shariat-Madar Z; Walker LA; Tekwani BL
Mol Cell Neurosci; 2016 Dec; 77():11-20. PubMed ID: 27678157
[TBL] [Abstract][Full Text] [Related]
8. Tricin, flavonoid from Njavara reduces inflammatory responses in hPBMCs by modulating the p38MAPK and PI3K/Akt pathways and prevents inflammation associated endothelial dysfunction in HUVECs.
Shalini V; Pushpan CK; G S; A J; A H
Immunobiology; 2016 Feb; 221(2):137-44. PubMed ID: 26514297
[TBL] [Abstract][Full Text] [Related]
9. Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death.
Gammoh N; Lam D; Puente C; Ganley I; Marks PA; Jiang X
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6561-5. PubMed ID: 22493260
[TBL] [Abstract][Full Text] [Related]
10. Suppression of caspase-11 expression by histone deacetylase inhibitors.
Heo H; Yoo L; Shin KS; Kang SJ
Biochem Biophys Res Commun; 2009 Jan; 378(1):79-83. PubMed ID: 19013432
[TBL] [Abstract][Full Text] [Related]
11. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation.
Feng Q; Su Z; Song S; Χu H; Zhang B; Yi L; Tian M; Wang H
Int J Mol Med; 2016 Sep; 38(3):812-22. PubMed ID: 27460781
[TBL] [Abstract][Full Text] [Related]
15. Suberoylanilide hydroxamic acid alleviates orthotopic liver transplantation‑induced hepatic ischemia‑reperfusion injury by regulating the AKT/GSK3β/NF‑κB and AKT/mTOR pathways in rat Kupffer cells.
Wang J; Deng M; Wu H; Wang M; Gong J; Bai H; Wu Y; Pan J; Chen Y; Li S
Int J Mol Med; 2020 Jun; 45(6):1875-1887. PubMed ID: 32236599
[TBL] [Abstract][Full Text] [Related]
16. Short form FLICE-inhibitory protein promotes TNFα-induced necroptosis in fibroblasts derived from CFLARs transgenic mice.
Shindo R; Yamazaki S; Ohmuraya M; Araki K; Nakano H
Biochem Biophys Res Commun; 2016 Nov; 480(1):23-28. PubMed ID: 27721066
[TBL] [Abstract][Full Text] [Related]
17. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
Zhang P; Guo Z; Wu Y; Hu R; Du J; He X; Jiao X; Zhu X
PLoS One; 2015; 10(8):e0136193. PubMed ID: 26287365
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
Yu C; Friday BB; Lai JP; McCollum A; Atadja P; Roberts LR; Adjei AA
Clin Cancer Res; 2007 Feb; 13(4):1140-8. PubMed ID: 17317822
[TBL] [Abstract][Full Text] [Related]
19. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
20. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.
Zhang Q; Zhu H; Xu X; Li L; Tan H; Cai X
Biochem Biophys Res Commun; 2015 Sep; 465(1):64-70. PubMed ID: 26235873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
